Busby W F, Shuker D E, Charnley G, Newberne P M, Tannenbaum S R, Wogan G N
Cancer Res. 1985 Mar;45(3):1367-71.
Two nitrosated bile acid conjugates, N-nitrosoglycocholic acid and N-nitrosotaurocholic acid, were examined for carcinogenicity in a 2-year study with male Fischer rats using a 6-week p.o. dosing protocol with a total of 300 mg compound/rat. Both compounds were approximately equally carcinogenic and induced significant levels of hepatocellular carcinoma in 54 to 70% of the animals at risk. Gastric tumors of the glandular and aglandular stomach were observed in 12 to 13% of the treated rats. Although the incidence was not significant, these levels were much higher than those in historic controls. Malignant liver and gastric tumors were not detected in vehicle control rats. Alkaline phosphatase-positive foci, putative early mucosal alterations which may precede neoplasia, were found in approximately 35% of the glandular stomachs of compound-treated rats but not in those of control rats.
在一项为期两年的研究中,使用为期6周的口服给药方案,以每只大鼠300毫克化合物的剂量,对两种亚硝化胆汁酸共轭物N-亚硝基甘胆酸和N-亚硝基牛磺胆酸在雄性费希尔大鼠中的致癌性进行了检测。两种化合物的致癌性大致相同,在54%至70%的受试动物中诱发了显著水平的肝细胞癌。在12%至13%的受试大鼠中观察到腺胃和非腺胃的胃部肿瘤。虽然发病率不显著,但这些水平远高于历史对照。在赋形剂对照大鼠中未检测到恶性肝脏和胃部肿瘤。在大约35%的经化合物处理的大鼠腺胃中发现了碱性磷酸酶阳性病灶,这是可能在肿瘤形成之前出现的早期黏膜改变,而在对照大鼠中未发现。